Pauline J. Bollen
Ede, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Influence of age and co-medication on dolutegravir glucuronidation in paediatric patients.
Journal: British journal of clinical pharmacology
Published: June 12, 2024
Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents.
Journal: Clinical pharmacokinetics
Published: July 17, 2023
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.
Journal: The lancet. HIV
Published: March 03, 2022
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.
Journal: The lancet. HIV
Published: July 21, 2021
The dolutegravir/valproic acid drug-drug interaction is primarily based on protein displacement.
Journal: The Journal of antimicrobial chemotherapy
Published: October 23, 2020
Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial.
Journal: The lancet. HIV
Published: February 11, 2020
The Effect of Pregnancy on the Pharmacokinetics of Total and Unbound Dolutegravir and Its Main Metabolite in Women Living With Human Immunodeficiency Virus.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 26, 2019
Development and validation of an UPLC-MS/MS bioanalytical method for simultaneous quantification of the antiretroviral drugs dolutegravir, elvitegravir, raltegravir, nevirapine and etravirine in human plasma.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: May 08, 2018
Crushing of dolutegravir fixed-dose combination tablets increases dolutegravir exposure.
Journal: The Journal of antimicrobial chemotherapy
Published: February 28, 2018
Dolutegravir is not removed during hemodialysis.
Journal: AIDS (London, England)
Published: May 12, 2016
Clinical pharmacokinetics and pharmacodynamics of dolutegravir used as a single tablet regimen for the treatment of HIV-1 infection.
Journal: Expert opinion on drug safety
Published: July 03, 2015
Effects of a chronic reduction of short-wavelength light input on melatonin and sleep patterns in humans: evidence for adaptation.
Journal: Chronobiology international
Published: March 07, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026